PSME2 Polyclonal Antibody | Invitrogen PA1-976 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

antibody

product name :

PSME2 Polyclonal Antibody

catalog :

PA1-976

quantity :

100 µL

price :

US 400

clonality :

polyclonal

host :

domestic rabbit

conjugate :

nonconjugated

reactivity :

human, mouse

application :

western blot, immunocytochemistry

citations: 14

Reference
Li J, Zhu Y, Li Y, He S, Wang D. Motor unit number index detects the effectiveness of surgical treatment in improving distal motor neuron loss in patients with incomplete cervical spinal cord injury. BMC Musculoskelet Disord. 2020;21:549 pubmed publisher
Huang Z, Fang T, Si Z, Li Y, Zhang L, Zheng C, et al. Imaging algorithm and multimodality evaluation of spinal osteoblastoma. BMC Musculoskelet Disord. 2020;21:240 pubmed publisher
Xu W, Lan Z, Huang Y. Intraoperative injection of absorbable gelatin sponge (AGS) mixed with cement followed by spinal decompression to treat elderly with vertebral hemangiomas. BMC Musculoskelet Disord. 2020;21:125 pubmed publisher
Liang Z, Cui J, Zhang J, He J, Tang J, Ren H, et al. Biomechanical evaluation of strategies for adjacent segment disease after lateral lumbar interbody fusion: is the extension of pedicle screws necessary?. BMC Musculoskelet Disord. 2020;21:117 pubmed publisher
Themistoklis K, Korfias S, Papasilekas T, Boviatsis K, Kokkoros A, Spartalis E, et al. Anterior Cervical Discectomy and Fusion combined with thyroid gland surgery, a tailored case and literature review. BMC Musculoskelet Disord. 2019;20:629 pubmed publisher
Zhang B, Zhou F, Wang L, Wang H, Jiang J, Guo Q, et al. A new decompression technique for upper lumbar fracture with neurologic deficit-comparison with traditional open posterior surgery. BMC Musculoskelet Disord. 2019;20:580 pubmed publisher
Mercier C, Dirix P, Ost P, Billiet C, Joye I, Vermeulen P, et al. A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET). BMC Cancer. 2019;19:876 pubmed publisher
Lespessailles E, Hammoud E, Toumi H, Ibrahim Nasser N. Consequences of bariatric surgery on outcomes in rheumatic diseases. Arthritis Res Ther. 2019;21:83 pubmed publisher
Huo J, Ji X, Su Z, Shang P, Gao F. Association of ADAMTS4 and ADAMTS5 polymorphisms with musculoskeletal degenerative diseases: a systematic review and meta-analysis. Biosci Rep. 2018;38: pubmed publisher
Doi T, Inoue H, Arai Y, Shirado O, Doi T, Yamazaki K, et al. Reliability and validity of a novel quality of life questionnaire for female patients with adolescent idiopathic scoliosis: Scoliosis Japanese Questionnaire-27: a multicenter, cross-sectional study. BMC Musculoskelet Disord. 2018;19:99 pubmed publisher
Hu P, Yu M, Liu X, Chen Z, Liu Z. How does the sagittal spinal balance of the scoliotic population deviate from the asymptomatic population?. BMC Musculoskelet Disord. 2018;19:36 pubmed publisher
Sadler S, Spink M, Ho A, De Jonge X, Chuter V. Restriction in lateral bending range of motion, lumbar lordosis, and hamstring flexibility predicts the development of low back pain: a systematic review of prospective cohort studies. BMC Musculoskelet Disord. 2017;18:179 pubmed publisher
Patel V, Andersson G, Garfin S, Resnick D, Block J. Utilization of CT scanning associated with complex spine surgery. BMC Musculoskelet Disord. 2017;18:52 pubmed publisher
Nielsen A, Kent P, Hestbaek L, Vach W, Kongsted A. Identifying subgroups of patients using latent class analysis: should we use a single-stage or a two-stage approach? A methodological study using a cohort of patients with low back pain. BMC Musculoskelet Disord. 2017;18:57 pubmed publisher

product information

Product Type :

Antibody

Product Name :

PSME2 Polyclonal Antibody

Catalog # :

PA1-976

Quantity :

100 µL

Price :

US 400

Clonality :

Polyclonal

Purity :

Ammonium sulfate precipitation

Host :

Rabbit

Reactivity :

Human, Mouse

Applications :

Immunocytochemistry: 1:10-1:100, Immunofluorescence: 1:10-1:100, Western Blot: 1:1,000

Species :

Human, Mouse

Isotype :

IgG

Storage :

-20° C, Avoid Freeze/Thaw Cycles

Description :

Proteolytic degradation is critical to the maintenance of appropriate levels of short-lived and regulatory proteins as important and diverse as those involved in cellular metabolism, heat shock and stress response, antigen presentation, modulation of cell surface receptors and ion channels, cell cycle regulation, transcription, and signalling factors. The ubiquitin-proteasome pathway deconstructs most proteins in the eukaryotic cell cytosol and nucleus. Others are degraded via the vacuolar pathway which includes endosomes, lysosomes, and the endoplasmic reticulum. The 26S proteasome is an ATP-dependent, multisubunit (approximately 31), barrel-shaped molecular machine with an apparent molecular weight of approximately 2.5 MDa. It consists of a 20S proteolytic core complex which is crowned at one or both ends by 19S regulatory subunit complexes. The 19S regulatory subunits recognize ubiquitinated proteins and play an essential role in unfolding and translocating targets into the lumen of the 20S subunit. An enzymatic cascade is responsible for the attachment of multiple ubiquitin molecules to lysine residues of proteins targeted for degradation. Several genetic diseases are associated with defects in the ubiquitin-proteasome pathway. Some examples of affected proteins include those linked to cystic fibrosis, Angelman's syndrome, and Liddle syndrome.

Immunogen :

Synthetic Peptide: M(1) A K P C G V R L S G E A R(14)

Format :

Liquid

Applications w/Dilutions :

Immunocytochemistry: 1:10-1:100, Immunofluorescence: 1:10-1:100, Western Blot: 1:1,000

Aliases :

11S regulator complex beta subunit; 11S regulator complex subunit beta; AA589371; Activator of multicatalytic protease subunit 2; AI788882; cell migration-inducing protein 22; MCP activator, 31-kD subunit; PA28b; Pa28b1; PA28beta; protease (prosome, macropain) 28 subunit, beta; proteasome (prosome, macropain) 28 subunit, beta; proteasome (prosome, macropain) activator subunit 2; proteasome (prosome, macropain) activator subunit 2 (PA28 beta); proteasome activator 28 subunit beta; proteasome activator 28-beta; proteasome activator complex subunit 2; proteasome activator hPA28 subunit beta; proteasome activator subunit 2; PSME2; REGbeta; REG-beta